Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Kelly L. Bolton(Washington University in St. Louis), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Yanis Tazi(Memorial Sloan Kettering Cancer Center), Jason Konner(Memorial Sloan Kettering Cancer Center), Kevin M. Elias(Harvard University), Charlie Gourley(Edinburgh Cancer Research), Ellen L. Goode(Mayo Clinic in Arizona), Esther Elishaev(University of Pittsburgh), Irenaeus C.C. Chan(Washington University in St. Louis), Angela Laslavic(University of Pittsburgh), Anna DeFazio(The University of Sydney), Denise Chen(Philadelphia College of Osteopathic Medicine), Stacey J. Winham(Mayo Clinic), Michael S. Anglesio(University of British Columbia), Rosario I. Corona(University of California, Los Angeles), Britta Weigelt(Memorial Sloan Kettering Cancer Center), Simon A. Gayther(The University of Texas Health Science Center at Houston), Catherine J. Kennedy(The University of Sydney), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Michael Churchman(Edinburgh Cancer Research), Zhuxuan Fu(Saint Luke's Health System), Rajmohan Murali(Memorial Sloan Kettering Cancer Center), Ronny Drapkin(University of Pennsylvania), Yoke-Eng Chiew(The University of Sydney), Kate Lawrenson(Texas A&M University – San Antonio), Sebastian M. Armasu(Mayo Clinic in Florida), Francesmary Modugno(University of Pittsburgh), Alison H. Brand(The University of Sydney), Beth Y. Karlan(University of California, Los Angeles), David G. Huntsman(BC Cancer Agency), Jenny Lester, Martin Köbel(University of Calgary), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Lea A. Moukarzel(Memorial Sloan Kettering Cancer Center), Brian Wiley(Washington University in St. Louis), Magdalena Sekowska(Wellcome Sanger Institute), Anna Piskorz(Cancer Research UK Cambridge Center), Julie M. Cunningham(Cancer Research UK)
Cited by 103
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k